stockrowDr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.
- Revenue
- −10.1%
- EPS
- −36.8%
- Free cash flow
- −70.5%
- Total debt
- +14.1%
Quarter to September 2026, against a year earlier
Follow RDY
Alert me
Dr. Reddy's Laboratories Ltd (RDY) Total debt
Dr. Reddy's Laboratories Ltd's total debt at the end of fiscal 2026 was $824.0M, up 50.6% from $547.0M in fiscal 2025. At the end of the quarter to 30 September 2026 it was $753.0M. Over the past ten years it has ranged from $164.0M (fiscal 2023) to $824.0M (fiscal 2026) — the current reading is the highest in ten years. Dr. Reddy's Laboratories Ltd ranks 15th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $824.0M | 50.64% |
| FY2025 | $547.0M | 126.97% |
| FY2024 | $241.0M | 46.95% |
| FY2023 | $164.0M | (63.23%) |
| FY2022 | $446.0M | 7.73% |
| FY2021 | $414.0M | 41.30% |
| FY2020 | $293.0M | (47.21%) |
| FY2019 | $555.0M | (28.66%) |
| FY2018 | $778.0M | 2.64% |
| FY2017 | $758.0M | 49.80% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $753.0M | (0.92%) |
| Jun 2026 | $760.0M | (7.77%) |
| Mar 2026 | $824.0M | 9.28% |
| Dec 2025 | $754.0M | 14.24% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ELAN Elanco Animal Health Incorporated compare | $3.9B |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $3.2B |
| VTRS Viatris Inc. compare | $1.7B |
| ALKS Alkermes plc compare | $1.5B |
| HIMS Hims & Hers Health, Inc. compare | $1.4B |
| RDY Dr. Reddy's Laboratories Ltd | $753.0M |
| LNTH Lantheus Holdings, Inc. compare | $571.7M |
| NBIX Neurocrine Biosciences, Inc. compare | $274.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $13.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on RDY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement